| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/03/1992 | EP0487756A1 Antibiotics napsamycins A-D, process for their production and their use as pharmaceuticals |
| 06/03/1992 | EP0487648A1 Odor-masked and stabilized compositions for treating keratinous tissue, skin conditions, and promoting wound healing |
| 06/03/1992 | EP0487629A1 Polypeptide analogs of apolipoprotein e, diagnostic systems and methods using the analogs |
| 06/03/1992 | EP0487627A1 Wound healing preparations containing heparanase |
| 06/03/1992 | EP0487617A1 Synthetic peptides that enhance cell binding. |
| 06/03/1992 | EP0487615A1 Ferritin analogs. |
| 06/03/1992 | EP0487610A1 Prohormone cleavage site blocking antibody |
| 06/03/1992 | EP0487587A1 Recombinant retroviruses delivering vector constructs to target cells |
| 06/03/1992 | EP0487525A1 Tuftsin analogs |
| 06/03/1992 | EP0467954A4 Preparation of liposome and lipid complex compositions |
| 06/03/1992 | EP0452391A4 A polypeptide having human monocyte chemotactic factor activity and a dna encoding said polypeptide |
| 06/03/1992 | EP0370036B1 Modified factor vii/viia |
| 06/03/1992 | CN1061623A The ciliary neurotrophic factor receptor |
| 06/03/1992 | CN1061607A Identification of cell density signal molecule |
| 06/03/1992 | CN1061606A Polypeptide compounds having growth hormone releasing activity |
| 06/03/1992 | CN1061605A Synthesis, products and its application for luteinizing hormone releasing hormone and antagonistic analogue |
| 06/02/1992 | US5118795 Viral inactivation by freeze drying; heating; reconstituting concentrate |
| 06/02/1992 | US5118794 Process for stabilizing human albumin solutions and the solution obtained |
| 06/02/1992 | US5118793 Substitution of arginine at position 44 for leucine; antithrombin |
| 06/02/1992 | US5118791 Biologically active polypeptides based on transforming growth factor-β |
| 06/02/1992 | US5118790 Analogs of hirudin |
| 06/02/1992 | US5118789 Obtained from larvae injured in body wall |
| 06/02/1992 | US5118670 Process and composition for increasing brain dopamine release |
| 06/02/1992 | US5118669 Peptides and intermediates therefor useful as antiallergic agents, vasodilators and immunoregulators |
| 06/02/1992 | US5118668 Peptide having sequence of appotinin where in one or more amino acids are replaced at position 15,16,17,18 34-39 and 52. by naturally occuring amino acid useful for hyperfibrinolytic or traumatic hemorrhage |
| 06/02/1992 | US5118667 Bone growth factors and inhibitors of bone resorption for promoting bone formation |
| 06/02/1992 | US5118666 Insulinotropic hormone |
| 06/02/1992 | US5118665 Enhance or restore resistance of mammals to damage caused by release of reactive oxygen species |
| 06/02/1992 | US5118624 Method for the stimulation of cell growth and the inhibition of cell proliferation by the utilization of selenodithiols such as selenodiglutathione |
| 06/02/1992 | US5118615 Gene insertion to an expression vector; hypotensive and diuretic |
| 06/02/1992 | US5118614 Concentrates of coagulation factors ii, vii, ix and x, method of their preparation and use |
| 06/02/1992 | US5118611 Adenocarcinoma antigen binding methods and reagents |
| 06/02/1992 | US5118601 Stabilization of mast cells by suppresion of mast cell activation |
| 06/02/1992 | US5118493 Composition having reduced nephrotoxocity comprising a fatty acid containing component and cyclosporine |
| 06/02/1992 | CA1302651C Fsh-releasing peptide |
| 06/02/1992 | CA1302650C Gnrh antagonists viii |
| 06/02/1992 | CA1302268C Pharmaceutical compositions containing diltiazem and an enzyme inhibitor |
| 06/02/1992 | CA1302260C Drug delivery system and method of making the same |
| 05/31/1992 | WO1992009627A1 Peptide with activity of inhibiting cancer cell infiltration, composite thereof, and cancer metastasis inhibitor |
| 05/31/1992 | CA2074945A1 Tumor cell invasion-inhibiting peptides, peptide complexes and cancer metastasis inhibitors |
| 05/31/1992 | CA2056800A1 Use of xanthines for the preparation of a medicament effective for inhibiting the effects of allograft reaction in humans |
| 05/31/1992 | CA2056661A1 Protein and preparation thereof |
| 05/30/1992 | WO1992009630A1 Imidoester cross-linked hemoglobin compositions |
| 05/30/1992 | CA2093650A1 Imidoester cross-linked hemoglobin compositions |
| 05/30/1992 | CA2056555A1 Immunostimulant agent containing interleukin-2 and 5'-deoxy-5-fluorouridine |
| 05/29/1992 | WO1992009294A1 Proteins purified from mammalian gestational tissue which control cell proliferation |
| 05/29/1992 | WO1992008802A1 Bispecific antibodies, method of production, and uses thereof |
| 05/29/1992 | WO1992008740A2 Receptor recognition factor and methods of use thereof |
| 05/29/1992 | WO1992008739A1 Antibodies that bind to a ligand-induced binding site on integrin and induce integrin activation |
| 05/29/1992 | WO1992008737A1 NEW HUMAN RECOMBINANT η INTERFERON |
| 05/29/1992 | WO1992008735A1 Novel cytokine |
| 05/29/1992 | WO1992008734A1 Hepatitis c virus asialoglycoproteins |
| 05/29/1992 | WO1992008733A1 Lhrh-antagonists |
| 05/29/1992 | WO1992008701A1 Retroviral protease inhibitors |
| 05/29/1992 | WO1992008700A1 Retroviral protease inhibitors |
| 05/29/1992 | WO1992008699A1 Retroviral protease inhibitors |
| 05/29/1992 | WO1992008698A1 Retroviral protease inhibitors |
| 05/29/1992 | WO1992008688A1 Retroviral protease inhibitors |
| 05/29/1992 | WO1992008493A1 Use of interleukin-6 to stimulate erythropoietin production |
| 05/29/1992 | WO1992008489A1 Treatment for inflammatory bowel disease |
| 05/29/1992 | WO1992008487A1 Recombinant feline coronavirus s proteins |
| 05/29/1992 | WO1992008484A1 Mycobacterium vaccae in the treatment of uveitis |
| 05/29/1992 | WO1992008483A1 CONTROLLING β-AMYLOID RELATED NEURONAL DEGENERATION BY ANTAGONIZING NGF-EFFECTED NEURONAL ACTIVITY |
| 05/29/1992 | WO1992008480A1 A β-TYPE TRANSFORMING GROWTH FACTOR |
| 05/29/1992 | WO1992008479A1 Tissue factor based prothrombin time reagent |
| 05/29/1992 | WO1992008478A1 Method of enhancing long-term storage stability of hemoglobin products |
| 05/29/1992 | WO1992008477A1 Therapeutic agent for corneal lesion |
| 05/29/1992 | WO1992008476A1 Peptides that inhibit platelet binding of adhesion molecules |
| 05/29/1992 | WO1992008474A2 Treatment of lung diseases |
| 05/29/1992 | WO1992008473A1 Therapeutic use of fibroblast growth factor |
| 05/29/1992 | WO1992008472A1 Antithrombosis agents |
| 05/29/1992 | WO1992006199A3 Antibody inductor peptides inhibiting retroviruses of the hiv type and antibodies specific for said peptides |
| 05/29/1992 | CA2101759A1 Antithrombosis agents |
| 05/29/1992 | CA2096441A1 Heterodimer of b-type transforming growth factors 2 and 3 |
| 05/29/1992 | CA2095840A1 Cytokine |
| 05/29/1992 | CA2074476A1 Proteins purified from mammalian gestational tissue which control cell proliferation |
| 05/29/1992 | CA2056222A1 Peptide compound, pharmaceutical composition and feed additive for animal |
| 05/29/1992 | CA2056143A1 The mac-1 binding site of icam-1 |
| 05/28/1992 | WO1992009299A1 Oral pharmaceutical composition containing cyclosporin and process for preparing same |
| 05/28/1992 | CA2072983A1 Oral pharmaceutical composition containing cyclosporin and process for preparing same |
| 05/27/1992 | EP0487512A1 Production of heterodimeric human fertility hormones |
| 05/27/1992 | EP0487410A2 Endothelin antagonists |
| 05/27/1992 | EP0487289A2 Cyclosporin immunoassay |
| 05/27/1992 | EP0487238A2 A method for blocking platelet adhesion to collagen |
| 05/27/1992 | EP0487207A1 Benzolactam analogs as antagonists of CCK |
| 05/27/1992 | EP0486959A1 Pharmaceutical composition of microparticles with controlled release and process of preparing it |
| 05/27/1992 | EP0486948A2 Retroviral protease inhibiting compounds |
| 05/27/1992 | EP0486917A2 Antiviral activity from the rep gene of adenoassociated virus-2 |
| 05/27/1992 | EP0486908A2 TNF-Muteins |
| 05/27/1992 | EP0486862A1 Chimeric fibroblast growth factor |
| 05/27/1992 | EP0486861A1 Active fragments of fibroblast growth factor |
| 05/27/1992 | EP0486854A1 Aqueous compositions containing calcitonin for the nasal administration |
| 05/27/1992 | EP0486652A1 Multivalent antigen-binding proteins |
| 05/27/1992 | EP0486627A1 Trypanosoma cruzi recombinant antigens and synthetic peptides for utilization inthe immunological diagnosis of chagas disease |
| 05/27/1992 | EP0486622A1 Direct radiolabeling of antibodies and other proteins with technetium or rhenium |
| 05/27/1992 | EP0486621A1 Nmda oxidizing agents for protecting neurons from injury |
| 05/27/1992 | EP0486584A1 Dopaminergic neurotrophic factor for treatment of parkinson's disease |
| 05/27/1992 | EP0486572A1 Improvements in granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
| 05/27/1992 | EP0486562A1 Mutant pseudorabies virus, and vaccines containing the same |
| 05/27/1992 | EP0486526A1 Tumour necrosis factor binding ligands. |